ABSTRACT
Nanomaterials, including nanoparticles (NPs), have provided unique opportunities in medicine, particularly in drug delivery and imaging. Due to the unprecedented materialistic properties and growing control over synthesis of various engineered nanomaterials, translation of nanoscale materials into tangible healthcare products can be foreseen. Upscaling remains a significant challenge, and given the production capability within academic institutions, supplying a nanomedicinal product at the global scale unfortunately sounds absurd. Nanomaterials indeed carry unprecedented properties, with a wide range of applications, including in medicine. To harvest the benefits of nanotechnology, experiments need to be conducted with NPs and not agglomerated particles. Nanoformulations are notorious for time-dependent changes and rearrangements guided via thermoenergetic principles. The concept of targeting has been found to be quite attractive in nanomedicine research. The more judicious view would be that nanomedicines can alter the discourse of tumors in a helpful way.
